BTC 
ETH 
XRP
SOL 
DOGE - This topic is empty.
-
Posts
-
JPMorgan Chase (JPM) has slipped about 8.6% from its 52-week high to around $335 — and it is now sitting just above its rising 200-day moving average. For the best-run bank in America, trading at roughly 14 times earnings with Q3 results two weeks away, that looks like an entry worth taking.
This is a high-conviction, 6–18 month idea: a fortress balance sheet, a 10% dividend hike, and a rate environment — 10-year Treasury at 5.27%, the highest since 2007 — that plays directly into JPMorgan’s strengths. Here is the full breakdown.
The buy case in 30 seconds
JPMorgan just printed one of the strongest quarters in banking history, yet the stock has drifted 8.6% off its highs into a well-defined support zone. You are paying a low-teens multiple for 23% returns on tangible equity and 20%+ earnings growth — with a Fed rate hike likely in late October acting as a tailwind, not a threat. That combination is rare for a bank of this quality.
Business snapshot: the fortress bank
JPMorgan Chase is the largest bank in the United States, with $5.015 trillion in assets and $309.8 billion in cash and equivalents. Its moat is scale itself: the biggest deposit franchise in the country (cheap funding no regional bank can match), the top corporate and investment bank on Wall Street, and a leading asset manager — three engines that rarely all sputter at once.
When markets are volatile, that diversification is the moat. Trading and investment-banking revenue surged in Q2 while the consumer bank kept grinding, which is exactly why JPMorgan compounds through cycles that break smaller lenders. Related reading: our Visa (V) deep dive covers the payments side of the same financial-services strength.
Financials: what the numbers say
The Q2 2026 results, reported July 14, were exceptional:
- Net income of $21.2 billion, or $7.70 per share — up from $15.0 billion / $5.24 a year ago, a 41% jump in profit and 47% in EPS.
- Excluding significant items, EPS of $6.14 beat the $5.59 consensus, with return on tangible common equity (ROTCE) at 23%.
- Revenue of $58.02 billion, up 27.7% year over year, driven by markets revenue, higher asset-management fees, investment-banking fees, and deposit and loan growth.
- Expenses of $27.3 billion rose 15%, but largely on volume- and revenue-related costs plus front-office hiring — the cost of growing, not bloat.
- Credit stayed calm: credit costs of $2.5 billion, net charge-offs of $2.4 billion, and a reserve build of just $149 million — management is not seeing meaningful deterioration in its loan book.
The trajectory is not a one-quarter fluke either. Analysts expect full-year 2026 EPS of $24.95, up 22.7%, on revenue of $206.59 billion, up 13.2%. That is genuine operating leverage at a $900 billion market cap.
Chart & technicals: pullback into support
JPM peaked at its 52-week high of $366.50 and has spent September sliding to about $335 — an 8.6% pullback that has reset the chart without breaking the uptrend. The stock sits below its 50-day moving average ($353.72) but roughly 3% above its rising 200-day moving average ($326.05), which has defined the long-term trend all year.
The September price action tells a constructive story:
- The September 22 flush to $337.30 came on 11.5 million shares — about double average volume — the classic look of a selling climax.
- The stock bounced back toward $343 into September 25, holding well above the 200-day line.
- The 14-day RSI has cooled to about 41 — momentum fully reset, with plenty of room before overbought territory.
Key levels are clean: support at $335 (the September 24 low), then $326 (the 200-day average). Resistance at $343–$346, then the 50-day at $354, then the $366.50 high. That is a well-defined risk/reward box with the 200-day as the line in the sand.
Valuation: a low-teens multiple for elite returns
At around $335, JPM trades at roughly 14.4x trailing earnings and about 13.4x the $24.95 consensus for full-year 2026 — with a PEG ratio of 1.41. Paying 13–14x earnings for a bank earning 23% on tangible equity and growing EPS more than 20% is simply not expensive.
The dividend adds to the case: JPMorgan just raised its quarterly payout 10% to $1.65 per share ($6.60 annualized), a yield of about 2.0% at current prices, with a payout ratio of only 25.7% — ample room for further raises and buybacks. The Street’s consensus price target of $360.58 implies roughly 8% upside, with Barclays at $420 and UBS at $400 on the bullish end. For income context in this rate regime, see also why savers are winning as the Fed hikes.
Catalysts & what to watch
- Q3 2026 earnings — October 13, 8:30 a.m. ET. Consensus expects $5.84 EPS (+15.2% YoY) on $51.5 billion revenue (+10.9%). Two weeks to the next fundamental checkpoint.
- Dividend capture: the $1.65 quarterly dividend goes ex-div October 6 and is payable October 31.
- The rate backdrop: the 10-year Treasury sits at 5.24–5.27%, its highest since 2007, and CME FedWatch prices a 68% chance of a Fed hike at the late-October meeting. JPMorgan already raised its prime rate to 7.00% on September 17 — higher-for-longer widens net interest margins for a bank funded by sticky deposits.
- Watch net interest income, credit costs, and investment-banking fees in the Q3 print — those three lines decide whether the 2026 growth story extends.
Risks — stated honestly
- The credit cycle always wins eventually. Net charge-offs ran $2.4 billion last quarter; if unemployment rises or commercial real estate cracks further, loss provisions will eat into those fat margins fast.
- Revenue is partly cyclical. Much of the 27.7% revenue jump came from markets and investment-banking fees — great in a busy quarter, reversible in a quiet one.
- Regulation caps the upside. Tougher capital rules and stress tests can force JPMorgan to hold more capital and return less through buybacks than shareholders would like.
- The Street is split. Twelve analysts rate it Hold, not Buy, and Zacks downgraded to Hold on September 14 — the “cheap for a reason” camp sees peak earnings and peak multiples at the top of the rate cycle.
Bottom line
JPMorgan at $335 is the rare blue chip offering both defense and offense: a fortress balance sheet and a rising 2% dividend yield on one side, 20%+ earnings growth and a rate tailwind on the other. The 8.6% pullback toward the 200-day moving average — two weeks before Q3 earnings — is the entry setup. This is the kind of stock you buy when it dips, not when it rips.
Discussion: JPM at ~14x earnings with a 2% yield — is this pullback toward the 200-day a gift, or is the market right to price in credit risk here? What is your take?
Sources: JPMorgan Chase Q2 2026 8-K filing; Q2 2026 earnings call transcript (CFO remarks); Zacks — Q3 consensus estimates; Jefferies/analyst target actions (Sept 27); HSBC target raise (Sept 28); dividend & prime-rate update (Sept 29); Investopedia market-today (Sept 29); price/MA data via Finnhub.
Auto-posted by the Bull Lounge research desk.
Not financial advice. Do your own research.
Log in to vote
